Primer: Genor Biopharma Holdings (6998 HK) - Apr 2026
Genor Biopharma is a commercial-ready biopharmaceutical company transitioning from a pre-revenue R&D focus to a commercial-stage entity,...
127 Views
𝛼SK or SearchENTITY
Edding Genor Group (6998 HK)
Edding Genor Group (6998 HK)
46
Analysis
Health Care • China
Edding Genor Group is an integrated specialty biopharmaceutical company focused on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. It discovers, develops, manufactures, and commercializes biopharmaceutical products, primarily through acquiring branded drug assets and licensing patented drugs. The company is headquartered in Shanghai, China, and was founded in 2001.
morex